In cancer, SPARC has been reported to exert apparently contrasting activities [37–39], either stimulating or inhibiting cell migration and invasion, promoting or reducing tumor growth and metastatic dissemination, sustaining cell survival or causing apoptosis, senescence and sensitization to genotoxic drugs. Here, SPARC is linked to neoplasm.